Inventiva S.A./€IVA

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Inventiva S.A.

Inventiva S.A. is a clinical-stage biopharmaceutical company based in France, focused on developing oral small molecule therapies for the treatment of diseases with unmet medical needs, particularly in the areas of fibrosis, lysosomal storage disorders, and oncology. The company’s leading product candidate is lanifibranor, which is currently in clinical trials for the treatment of non-alcoholic steatohepatitis (NASH). Founded in 2012, Inventiva leverages its proprietary technology platform to identify and develop innovative compounds. The company's research and development operations are concentrated in Daix, France. Inventiva’s competitive strength lies in its robust pipeline and strategic collaborations with partners in the pharmaceutical industry. Sources: 1. https://inventivapharma.com/en/ 2. https://ir.inventivapharma.com/ 3. https://www.wallstreet-online.de/nachricht/14672309-inventiva-reports-financial-results-quarter-ended-september-30-2021

Ticker

€IVA
Sector

Primary listing

PAR

Employees

116

Inventiva S.A. Metrics

BasicAdvanced
€540M
-
-€3.08
0.61
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €IVA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs